VIEMED HEALTHCARE INC (VMD) Fundamental Analysis & Valuation

NASDAQ:VMD • CA92663R1055

Current stock price

9.66 USD
+0.17 (+1.79%)
Last:

This VMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. VMD Profitability Analysis

1.1 Basic Checks

  • In the past year VMD was profitable.
  • In the past year VMD had a positive cash flow from operations.
  • Each year in the past 5 years VMD has been profitable.
  • Each year in the past 5 years VMD had a positive operating cash flow.
VMD Yearly Net Income VS EBIT VS OCF VS FCFVMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

1.2 Ratios

  • VMD has a Return On Assets of 7.50%. This is amongst the best in the industry. VMD outperforms 89.00% of its industry peers.
  • VMD has a better Return On Equity (10.55%) than 73.00% of its industry peers.
  • VMD's Return On Invested Capital of 9.25% is fine compared to the rest of the industry. VMD outperforms 80.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for VMD is in line with the industry average of 8.50%.
  • The 3 year average ROIC (8.65%) for VMD is below the current ROIC(9.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.5%
ROE 10.55%
ROIC 9.25%
ROA(3y)6.82%
ROA(5y)6.7%
ROE(3y)9.37%
ROE(5y)8.82%
ROIC(3y)8.65%
ROIC(5y)8.12%
VMD Yearly ROA, ROE, ROICVMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 5.53%, VMD belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
  • VMD's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 7.66%, VMD is in the better half of the industry, outperforming 73.00% of the companies in the same industry.
  • VMD's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 57.52%, VMD belongs to the top of the industry, outperforming 81.00% of the companies in the same industry.
  • VMD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.66%
PM (TTM) 5.53%
GM 57.52%
OM growth 3Y7.34%
OM growth 5Y-16.31%
PM growth 3Y7.35%
PM growth 5Y-25.45%
GM growth 3Y-1.95%
GM growth 5Y-1.17%
VMD Yearly Profit, Operating, Gross MarginsVMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. VMD Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so VMD is still creating some value.
  • The number of shares outstanding for VMD has been reduced compared to 1 year ago.
  • VMD has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, VMD has a worse debt to assets ratio.
VMD Yearly Shares OutstandingVMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
VMD Yearly Total Debt VS Total AssetsVMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 6.28 indicates that VMD is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.28, VMD belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
  • The Debt to FCF ratio of VMD is 1.04, which is an excellent value as it means it would take VMD, only 1.04 years of fcf income to pay off all of its debts.
  • VMD's Debt to FCF ratio of 1.04 is amongst the best of the industry. VMD outperforms 86.00% of its industry peers.
  • VMD has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.08, VMD is doing good in the industry, outperforming 77.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.04
Altman-Z 6.28
ROIC/WACC1.04
WACC8.92%
VMD Yearly LT Debt VS Equity VS FCFVMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.3 Liquidity

  • VMD has a Current Ratio of 1.18. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
  • VMD has a Current ratio (1.18) which is in line with its industry peers.
  • VMD has a Quick Ratio of 1.06. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.06, VMD is doing worse than 62.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.06
VMD Yearly Current Assets VS Current LiabilitesVMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. VMD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.14% over the past year.
  • The earnings per share for VMD have been decreasing by -13.86% on average. This is quite bad
  • VMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.52%.
  • VMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.53% yearly.
EPS 1Y (TTM)32.14%
EPS 3Y35.12%
EPS 5Y-13.86%
EPS Q2Q%40%
Revenue 1Y (TTM)20.52%
Revenue growth 3Y24.87%
Revenue growth 5Y15.53%
Sales Q2Q%25.51%

3.2 Future

  • Based on estimates for the next years, VMD will show a very strong growth in Earnings Per Share. The EPS will grow by 32.39% on average per year.
  • The Revenue is expected to grow by 15.22% on average over the next years. This is quite good.
EPS Next Y31.03%
EPS Next 2Y30.09%
EPS Next 3Y32.39%
EPS Next 5YN/A
Revenue Next Year15.99%
Revenue Next 2Y15.49%
Revenue Next 3Y15.22%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
VMD Yearly Revenue VS EstimatesVMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
VMD Yearly EPS VS EstimatesVMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

5

4. VMD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 26.11, which means the current valuation is very expensive for VMD.
  • 61.00% of the companies in the same industry are more expensive than VMD, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.42. VMD is around the same levels.
  • With a Price/Forward Earnings ratio of 19.93, VMD is valued on the expensive side.
  • 61.00% of the companies in the same industry are more expensive than VMD, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, VMD is valued at the same level.
Industry RankSector Rank
PE 26.11
Fwd PE 19.93
VMD Price Earnings VS Forward Price EarningsVMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 83.00% of the companies in the same industry are more expensive than VMD, based on the Enterprise Value to EBITDA ratio.
  • VMD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 31.25
EV/EBITDA 7.4
VMD Per share dataVMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • VMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of VMD may justify a higher PE ratio.
  • A more expensive valuation may be justified as VMD's earnings are expected to grow with 32.39% in the coming years.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y30.09%
EPS Next 3Y32.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VMD Dividend Analysis

5.1 Amount

  • No dividends for VMD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VMD Fundamentals: All Metrics, Ratios and Statistics

VIEMED HEALTHCARE INC

NASDAQ:VMD (4/24/2026, 8:13:25 PM)

9.66

+0.17 (+1.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners66.84%
Inst Owner Change0.16%
Ins Owners14.18%
Ins Owner Change19%
Market Cap372.88M
Revenue(TTM)270.28M
Net Income(TTM)14.93M
Analysts80
Price Target13.26 (37.27%)
Short Float %1.18%
Short Ratio1.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.95%
Min EPS beat(2)-0.99%
Max EPS beat(2)10.89%
EPS beat(4)1
Avg EPS beat(4)1.98%
Min EPS beat(4)-0.99%
Max EPS beat(4)10.89%
EPS beat(8)2
Avg EPS beat(8)-6.58%
EPS beat(12)3
Avg EPS beat(12)-6.26%
EPS beat(16)4
Avg EPS beat(16)-11.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.02%
Min Revenue beat(2)-2.93%
Max Revenue beat(2)-1.11%
Revenue beat(4)0
Avg Revenue beat(4)-2.12%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)-1.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.8%
Revenue beat(12)7
Avg Revenue beat(12)-0.25%
Revenue beat(16)10
Avg Revenue beat(16)0.22%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-10%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.13%
EPS NY rev (3m)-5.88%
Revenue NQ rev (1m)-1.65%
Revenue NQ rev (3m)-3.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.14%
Valuation
Industry RankSector Rank
PE 26.11
Fwd PE 19.93
P/S 1.38
P/FCF 31.25
P/OCF 7.18
P/B 2.63
P/tB 4.59
EV/EBITDA 7.4
EPS(TTM)0.37
EY3.83%
EPS(NY)0.48
Fwd EY5.02%
FCF(TTM)0.31
FCFY3.2%
OCF(TTM)1.34
OCFY13.92%
SpS7
BVpS3.67
TBVpS2.11
PEG (NY)0.84
PEG (5Y)N/A
Graham Number5.52517 (-42.8%)
Profitability
Industry RankSector Rank
ROA 7.5%
ROE 10.55%
ROCE 13.1%
ROIC 9.25%
ROICexc 10.11%
ROICexgc 17.33%
OM 7.66%
PM (TTM) 5.53%
GM 57.52%
FCFM 4.41%
ROA(3y)6.82%
ROA(5y)6.7%
ROE(3y)9.37%
ROE(5y)8.82%
ROIC(3y)8.65%
ROIC(5y)8.12%
ROICexc(3y)9.66%
ROICexc(5y)9.65%
ROICexgc(3y)14.46%
ROICexgc(5y)12.54%
ROCE(3y)12.25%
ROCE(5y)11.5%
ROICexgc growth 3Y32.34%
ROICexgc growth 5Y-10.1%
ROICexc growth 3Y10.58%
ROICexc growth 5Y-19.29%
OM growth 3Y7.34%
OM growth 5Y-16.31%
PM growth 3Y7.35%
PM growth 5Y-25.45%
GM growth 3Y-1.95%
GM growth 5Y-1.17%
F-Score6
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.04
Debt/EBITDA 0.23
Cap/Depr 139.74%
Cap/Sales 14.79%
Interest Coverage 23.7
Cash Conversion 105.26%
Profit Quality 79.89%
Current Ratio 1.18
Quick Ratio 1.06
Altman-Z 6.28
F-Score6
WACC8.92%
ROIC/WACC1.04
Cap/Depr(3y)136%
Cap/Depr(5y)145.81%
Cap/Sales(3y)15.3%
Cap/Sales(5y)15.85%
Profit Quality(3y)92.75%
Profit Quality(5y)77.34%
High Growth Momentum
Growth
EPS 1Y (TTM)32.14%
EPS 3Y35.12%
EPS 5Y-13.86%
EPS Q2Q%40%
EPS Next Y31.03%
EPS Next 2Y30.09%
EPS Next 3Y32.39%
EPS Next 5YN/A
Revenue 1Y (TTM)20.52%
Revenue growth 3Y24.87%
Revenue growth 5Y15.53%
Sales Q2Q%25.51%
Revenue Next Year15.99%
Revenue Next 2Y15.49%
Revenue Next 3Y15.22%
Revenue Next 5YN/A
EBIT growth 1Y29.48%
EBIT growth 3Y34.04%
EBIT growth 5Y-3.31%
EBIT Next Year201.57%
EBIT Next 3Y60.9%
EBIT Next 5YN/A
FCF growth 1Y805.24%
FCF growth 3Y34.99%
FCF growth 5Y-11.57%
OCF growth 1Y32.81%
OCF growth 3Y23.22%
OCF growth 5Y8.14%

VIEMED HEALTHCARE INC / VMD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of VIEMED HEALTHCARE INC (VMD) stock?

ChartMill assigns a fundamental rating of 6 / 10 to VMD.


Can you provide the valuation status for VIEMED HEALTHCARE INC?

ChartMill assigns a valuation rating of 5 / 10 to VIEMED HEALTHCARE INC (VMD). This can be considered as Fairly Valued.


What is the profitability of VMD stock?

VIEMED HEALTHCARE INC (VMD) has a profitability rating of 7 / 10.


How financially healthy is VIEMED HEALTHCARE INC?

The financial health rating of VIEMED HEALTHCARE INC (VMD) is 7 / 10.